Endocrine therapy in obese patients with primary breast cancer: Another piece of evidence in an unfinished puzzle

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 925-931

  Wolters, R ^a   Schwentner, L ^b   Regierer, A ^c   Wischnewsky, M ^a   Kreienberg, R ^b   Wockel A ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aromatase inhibitor; Breast cancer; Endocrine therapy; Menopausal status; Obesity; Tamoxifen

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; NOTTINGHAM PROGNOSTIC INDEX; OBESITY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OBESITY; RECEPTORS, STEROID; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAMOXIFEN; YOUNG ADULT;

EID: 84856226492     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1874-7     Document Type: Article

References (26)

1. LM Morimoto E White Z Chen RT Chlebowski J Hays L Kuller AM Lopez J Manson KL Margolis PC Muti ML Stefanick A McTiernan 2002 Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Cancer Cause Control 13 8 741 751 10.1023/A:1020239211145
2. GK Reeves K Pirie V Beral J Green E Spencer D Bull Million Women Study Collaboration 2007 Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study Br Med J 335 7630 1134 10.1136/bmj.39367.495995.AE
3. S Loi RL Milne ML Friedlander MR McCredie GG Giles JL Hopper KA Phillips 2005 Obesity and outcomes in premenopausal and postmenopausal breast cancer Cancer Epidemiol Biomark 14 7 1686 1691 10.1158/1055-9965.EPI-05-0042
4. M Protani M Coory JH Martin 2010 Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Breast Cancer Res Treat 123 627 635 20571870 10.1007/s10549-010-0990-0
5. JJ Dignam K Wieand KA Johnson B Fisher L Xu EP Mamounas 2003 Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer J Natl Cancer Inst 95 19 1467 1476 14519753 10.1093/jnci/djg060 1:CAS:528:DC%2BD3sXnvVCjtrs%3D
6. EE Calle C Rodriguez K Walker-Thurmond MJ Thun 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 1625 1638 12711737 10.1056/NEJMoa021423
7. MK Whiteman SD Hillis KM Curtis JA McDonald PA Wingo PA Marchbanks 2005 Body mass and mortality after breast cancer diagnosis Cancer Epidemiol Biomark 14 8 2009 2014 10.1158/1055-9965.EPI-05-0106
8. B Majed T Moreau K Senouci RJ Salmon A Fourquet B Asselain 2008 Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111 2 329 342 17939036 10.1007/s10549-007-9785-3
9. JM Petrelli EE Calle C Rodriguez MJ Thun 2002 Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women Cancer Cause Control 13 4 325 332 10.1023/A:1015288615472
10. M Ewertz MB Jensen KÁ Gunnarsdóttir I Højris EH Jakobsen D Nielsen LE Stenbygaard UB Tange S Cold 2011 Effect of obesity on prognosis after early-stage breast cancer J Clin Oncol 29 1 25 31 21115856 10.1200/JCO.2010.29.7614
11. WHO/Europe (2001) Obesity. http://www.euro.who.int/en/what-we-do/health- topics/noncommunicable-diseases/obesity. Accessed 27 May 2011
12. I Sestak W Distler JF Forbes M Dowsett A Howell J Cuzick 2010 Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial J Clin Oncol 28 21 3411 3415 20547990 10.1200/JCO.2009.27.2021 1:CAS:528:DC%2BC3cXhtVGis7bF
13. Pfeiler G, Stöger H, Fesl C, Singer C, Seifert M, Jakesz R, Dubsky P, Samonigg H, Greil R, Menzel C, Heck D, Gnant M on behalf of the ABCSG (2010) Impact of body mass index (BMI) on the efficacy of endocrine therapy in postmenopausal breast cancer patients-an analysis of the ABCSG 6 and 6a trial. http://www.abstracts2view.com/sabcs10/viewp.php?nu=PD09-05
14. Pfeiler G, Königsberg R, Fesl C, Mlineritsch B, Stoeger H, Singer CF, Pöstlberger S, Steger GG, Seifert M, Dubsky P, Taucher S, Samonigg H, Bjelic-Radisic V, Greil R, Marth C, Gnant M (2011) Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. J Clin Oncol 29:2653-2659
15. PJ Goodwin KI Pritchard 2010 Obesity and hormone therapy in breast cancer: an unfinished puzzle J Clin Oncol 28 21 3405 3407 20548001 10.1200/JCO.2010.29.5113 1:CAS:528:DC%2BC3cXhtVGis7bK
16. A Wöckel D Varga Z Atassi C Kurzeder R Wolters M Wischnewsky C Wulff R Kreienberg 2010 Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study Onkologie 33 1-2 21 28 20164658
17. K Hancke MD Denkinger J König C Kurzeder A Wöckel D Herr M Blettner R Kreienberg 2010 Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study Ann Oncol 21 4 748 753 19825884 10.1093/annonc/mdp364 1:STN:280:DC%2BC3c3htFGlsw%3D%3D
18. A Wöckel C Kurzeder V Geyer I Novopashenny R Wolters M Wischnewsky R Kreienberg D Varga 2010 Effects of guideline adherence in primary breast cancer-a 5-year multi-center cohort study of 3976 patients Breast 19 2 120 127 20117932 10.1016/j.breast.2009.12.006
19. Regierer AC, Wolters R, Kurzeder C, Wöckel A, Novopashenny I, Possinger K, Wischnewsky MB, Kreienberg R (2011) High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS? Breast Cancer Res Treat. doi: 10.1007/s1054901013349
20. D Varga M Wischnewsky Z Atassi R Wolters V Geyer K Strunz R Kreienberg A Woeckel 2010 Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology 78 3-4 189 195 20414007 10.1159/000313698
21. BO Maehle S Tretli R Skjaerven T Thorsen 2001 Premorbid body weight and its relation to primary tumour diameter in breast cancer patients: its dependence on estrogen and progesterone receptor status Breast Cancer Res Treat 68 159 169 11688519 10.1023/A:1011977118921 1:STN:280:DC%2BD3Mnjs1agtw%3D%3D
22. G Berclaz S Li KN Price AS Coates M Castiglinone-Gertsch CM Rudenstam SB Holmberg J Lindtner D Erien J Collins R Snyder B Thürlimann MF Fey C Mendiola ID Werner E Simoncini D Crivellari RD Gelber A Goldhirsch International Breast Cancer Study Group 2004 Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience Ann Oncol 15 875 884 15151943 10.1093/annonc/mdh222 1:STN:280: DC%2BD2c3lt1yqtw%3D%3D
23. RJ Cleveland SM Eng PE Abrahamson JA Britton SL Teitelbaum AI Neugut MD Gammon 2007 Weight gain prior to diagnosis and survival from breast cancer Cancer Epidemiol Biomark Prev 16 1803 1811 10.1158/1055-9965.EPI-06-0889
24. HS Feigelson AV Patel LR Teras TS Gansler MJ Thun EE Calle 2006 Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women Cancer 1107 12 21 10.1002/cncr.21965
25. Schmid P, Possinger K, Bohm R, Chaudri V, Verbeek V, Grosse Y, Luftner D, Petrides P, Sezer O, Wischnewsky M (2000) Body mass index as predictive parameter for response and time to progression (TTP) in advanced breast cancer patients treated with letrozole or megestrol acetate. Proc Am Soc Clin Oncol 19:2000 (abstr 398)
26. Michaud LB, Buzdar AU, Rubin S, Steinberg M, Yin H, Aaronson L, Nabholtz JM (2002) The efficacy of anastrozole is not dependent upon body mass index (BMI) in postmenopausal women with advanced breast cancer (BC). Proc Am Soc Clin Oncol 21:2002 (abstr 219)